Adrian O Ma, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 9 carriers
- Office
- 1
Offices
1 location
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
34 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ma’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A45522 · Current
Licensed to practise in California · since 1988 · expires 2027-12-31 · University of New South Wales Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$990,888
Medicare paid this office $990,888 for 568 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 206 | $352,226 | $1,702 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 206 | $182,802 | $442 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 117 | $118,139 | $984 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 420 | $77,647 | $179 |
| Long return visit (40+ min) | 276 | $70,238 | $181 |
See all 21 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 206 | $352,226 | $1,702 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 206 | $182,802 | $442 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 117 | $118,139 | $984 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 420 | $77,647 | $179 |
| Long return visit (40+ min) | 276 | $70,238 | $181 |
| Return visit (30+ min) | 357 | $69,674 | $128 |
| New patient visit (45+ min) | 126 | $21,546 | $171 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 206 | $16,368 | $79 |
| New patient visit (60+ min) | 39 | $8,780 | $225 |
| Injection of drug or substance into vein | 206 | $8,737 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $7,662 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,356 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $6,887 | $76 |
| Programming of dual lead pacemaker system | 49 | $6,881 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 406 | $5,946 | $14 |
| Ultrasound of both sides of head and neck blood flow | 33 | $5,474 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $4,497 | $66 |
| Injection, regadenoson, 0.1 mg | 201 | $3,964 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 117 | $2,943 | $25 |
| Infusion, normal saline solution, 250 cc | 206 | $857 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $226 | $11 |
Procedures Medicare counted
| Pacemaker insertion or repair | 13 | More than 64% of doctors who do this |
Who their Medicare patients are
568 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 25% · Women 52% · Also on Medicaid 58% · Health risk score 1.71. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 49% · Coronary heart disease 45% · Atrial fibrillation 34% · Chronic kidney disease 33% · Heart failure 29% · COPD 14% · Cancer 11% · Dementia 11% · Depression 10% · Stroke 10%.
The office billed $1,812,792, Medicare allowed $1,254,237 and paid $990,888; for 6,402 services of 47 kinds; $4,910 of it was for drugs given in the office and $985,978 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 568 | 6,402 | 78 | 1.71 | $1,812,792 | $990,888 |
| 2023 | 681 | 11,485 | 79 | 1.56 | $2,002,594 | $1,029,539 |
| 2022 | 792 | 14,319 | 79 | 1.84 | $1,939,052 | $1,000,940 |
| 2021 | 794 | 14,585 | 78 | 1.87 | $1,937,436 | $1,000,000 |
| 2020 | 698 | 13,282 | 79 | 2.08 | $1,532,120 | $747,067 |
| 2019 | 901 | 19,704 | 79 | 1.95 | $2,018,235 | $1,042,926 |
| 2018 | 842 | 18,128 | 79 | 1.83 | $1,903,930 | $937,677 |
| 2017 | 825 | 17,944 | 79 | 1.88 | $1,818,906 | $856,338 |
| 2016 | 745 | 16,908 | 79 | 1.85 | $1,721,160 | $761,011 |
| 2015 | 764 | 16,095 | 79 | 1.95 | $1,655,981 | $736,838 |
| 2014 | 871 | 15,090 | 80 | 1.68 | $1,694,785 | $774,228 |
| 2013 | 936 | 6,521 | 79 | 1.83 | $1,768,377 | $675,440 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 251 | $403,755 | $1,609 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 251 | $209,537 | $417 |
| Return visit (30+ min) | 421 | $90,571 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 455 | $78,046 | $168 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 54 | $51,717 | $958 |
| Long return visit (40+ min) | 185 | $38,327 | $168 |
| New patient visit (45+ min) | 165 | $26,253 | $159 |
| Injection, regadenoson, 0.1 mg | 129 | $20,438 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 253 | $18,540 | $73 |
| Injection of drug or substance into vein | 252 | $10,193 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $9,105 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 141 | $8,709 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,518 | $155 |
| Programming of dual lead pacemaker system | 57 | $8,208 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $7,639 | $73 |
| New patient visit (60+ min) | 35 | $7,414 | $212 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 469 | $6,835 | $13 |
| Ultrasound of both sides of head and neck blood flow | 32 | $5,213 | $163 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $2,650 | $241 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $2,288 | $74 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 123 | $1,837 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 54 | $1,274 | $24 |
| Ultrasound study of arm and leg arteries | 13 | $1,043 | $80 |
| Infusion, normal saline solution, 250 cc | 252 | $1,020 | None |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 12 | $287 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $253 | $11 |
| Heart rhythm recording of continous external ekg over 8-15 days | 12 | $162 | $14 |
2022: 26 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 229 | $371,234 | $1,614 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 229 | $192,465 | $418 |
| Return visit (30+ min) | 470 | $103,671 | $118 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 83 | $86,031 | $1,012 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 462 | $75,334 | $161 |
| New patient visit (45+ min) | 179 | $28,781 | $161 |
| Long return visit (40+ min) | 145 | $28,204 | $171 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 229 | $16,857 | $73 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $13,554 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $10,888 | $181 |
| Injection of drug or substance into vein | 229 | $9,814 | $43 |
| Programming of dual lead pacemaker system | 65 | $9,488 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $8,175 | $65 |
| Ultrasound of both sides of head and neck blood flow | 48 | $6,898 | $144 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 441 | $6,149 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $5,845 | $94 |
| New patient visit (60+ min) | 27 | $5,573 | $206 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 222 | $2,974 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 83 | $2,039 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 22 | $1,678 | $76 |
| Infusion, normal saline solution, 250 cc | 229 | $968 | None |
| Administration of influenza virus vaccine | 12 | $455 | $38 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $253 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $224 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $221 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $148 | $13 |
2021: 29 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 211 | $354,557 | $1,672 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 211 | $179,375 | $424 |
| Return visit (30+ min) | 485 | $115,290 | $118 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 101 | $85,186 | $804 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 391 | $69,565 | $175 |
| Long return visit (40+ min) | 147 | $29,607 | $173 |
| New patient visit (45+ min) | 142 | $23,027 | $162 |
| Ultrasound of both sides of head and neck blood flow | 122 | $17,562 | $144 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 214 | $15,745 | $73 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $15,625 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $12,638 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $11,742 | $186 |
| Programming of dual lead pacemaker system | 72 | $10,017 | $74 |
| Injection of drug or substance into vein | 215 | $9,748 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,692 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 425 | $6,170 | $14 |
| New patient visit (60+ min) | 27 | $5,543 | $205 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 202 | $3,764 | None |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 101 | $2,557 | $24 |
| Injection, regadenoson, 0.1 mg | 11 | $2,093 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $1,618 | $77 |
| Infusion, normal saline solution, 250 cc | 215 | $949 | None |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $384 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $266 | $12 |
| Administration of influenza virus vaccine | 12 | $264 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $255 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 12 | $246 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $246 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $165 | $14 |
2020: 31 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 164 | $278,373 | $1,677 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 164 | $139,025 | $419 |
| Return visit (30+ min) | 426 | $87,873 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 327 | $59,406 | $181 |
| Long return visit (40+ min) | 185 | $29,455 | $129 |
| Ultrasound of both sides of head and neck blood flow | 103 | $17,099 | $166 |
| New patient visit (45+ min) | 102 | $15,795 | $155 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 192 | $13,598 | $69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 172 | $12,644 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $11,196 | $187 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 11 | $8,661 | $787 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $8,097 | $67 |
| Programming of dual lead pacemaker system | 62 | $7,434 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $6,548 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 309 | $5,061 | $16 |
| Injection of drug or substance into vein | 110 | $4,682 | $43 |
| New patient visit (60+ min) | 23 | $4,531 | $197 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 150 | $4,111 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $3,448 | $265 |
| Injection, regadenoson, 0.1 mg | 17 | $3,192 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,911 | $80 |
| External ekg recording for more than 48 hours up to 21 days | 48 | $1,400 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 48 | $1,223 | $25 |
| Ultrasound study of arm and leg arteries | 26 | $1,154 | $44 |
| Short return visit (20+ min) | 12 | $704 | $59 |
| Infusion, normal saline solution, 250 cc | 109 | $442 | None |
| Administration of influenza virus vaccine | 17 | $356 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 17 | $333 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $273 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $148 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $86 | $8 |
2019: 28 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 273 | $431,534 | $1,569 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 273 | $197,689 | $359 |
| Return visit (30+ min) | 560 | $108,432 | $102 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 387 | $69,396 | $177 |
| Long return visit (40+ min) | 206 | $34,434 | $134 |
| New patient visit (45+ min) | 186 | $28,286 | $152 |
| Ultrasound of both sides of head and neck blood flow | 130 | $22,385 | $172 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 280 | $20,128 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $19,221 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $17,991 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 203 | $14,188 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $12,218 | $95 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 269 | $8,262 | None |
| Programming of dual lead pacemaker system | 72 | $7,215 | $54 |
| New patient visit (60+ min) | 38 | $7,099 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 428 | $7,070 | $16 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $4,722 | $262 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 51 | $4,244 | $80 |
| Ultrasound study of arm and leg arteries | 57 | $3,300 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,112 | $124 |
| Short return visit (20+ min) | 23 | $1,727 | $72 |
| External ekg recording for more than 48 hours up to 21 days | 58 | $1,634 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 59 | $1,453 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 24 | $492 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 24 | $330 | $14 |
| Administration of influenza virus vaccine | 13 | $267 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $147 | $8 |
2018: 34 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 243 | $376,290 | $1,542 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 243 | $146,625 | $300 |
| Return visit (30+ min) | 560 | $105,450 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 398 | $71,768 | $177 |
| Long return visit (40+ min) | 176 | $28,475 | $133 |
| New patient visit (45+ min) | 184 | $27,250 | $148 |
| Ultrasound of both sides of head and neck blood flow | 113 | $21,545 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $19,350 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 257 | $18,202 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $17,464 | $182 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $16,528 | $787 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 72 | $10,860 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $9,798 | $67 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 237 | $7,872 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 472 | $7,848 | $16 |
| Programming of dual lead pacemaker system | 75 | $6,428 | $48 |
| New patient visit (60+ min) | 30 | $5,480 | $183 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,984 | $249 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $3,981 | $190 |
| Short return visit (20+ min) | 52 | $3,678 | $69 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,908 | $86 |
| Ultrasound study of arm and leg arteries | 37 | $2,466 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,444 | $122 |
| External ekg recording for more than 48 hours up to 21 days | 42 | $1,164 | $28 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,087 | $99 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 43 | $1,005 | $23 |
| Influenza vaccine, quadrivalent derived from recombinant dna | 18 | $941 | $52 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 21 | $493 | $23 |
| Administration of influenza virus vaccine | 18 | $463 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $342 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $229 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $184 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 19 | $152 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $32 | $3 |
2017: 34 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 231 | $341,756 | $1,479 |
| Return visit (30+ min) | 546 | $113,468 | $98 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 231 | $106,493 | $231 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 356 | $71,985 | $199 |
| Long return visit (40+ min) | 176 | $29,420 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $20,100 | $181 |
| New patient visit (45+ min) | 140 | $19,871 | $142 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 246 | $18,443 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $17,944 | $65 |
| Ultrasound of both sides of head and neck blood flow | 102 | $15,777 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $10,563 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $10,283 | $58 |
| Programming of dual lead pacemaker system | 81 | $7,350 | $50 |
| Short return visit (20+ min) | 94 | $7,321 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 431 | $7,215 | $16 |
| New patient visit (60+ min) | 35 | $6,362 | $182 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 229 | $5,984 | None |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,556 | $505 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 63 | $5,324 | $82 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,751 | $250 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,051 | $122 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 11 | $2,099 | $95 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 11 | $1,658 | $151 |
| Ultrasound study of arm and leg arteries | 27 | $1,127 | $40 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,085 | $99 |
| External ekg recording for more than 48 hours up to 21 days | 35 | $1,017 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 35 | $881 | $24 |
| Administration of influenza virus vaccine | 20 | $646 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $542 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $364 | $13 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 20 | $347 | $17 |
| Blood test, clotting time | 11 | $232 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 28 | $213 | $8 |
| Insertion of needle into vein for collection of blood sample | 11 | $129 | $3 |
2016: 31 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 180 | $259,236 | $1,432 |
| Return visit (30+ min) | 523 | $112,192 | $96 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 178 | $81,089 | $227 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 368 | $72,105 | $194 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 53 | $25,861 | $488 |
| Long return visit (40+ min) | 155 | $24,493 | $129 |
| New patient visit (45+ min) | 129 | $17,960 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $17,649 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 94 | $17,391 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 234 | $16,860 | $71 |
| Short return visit (20+ min) | 135 | $11,703 | $66 |
| Ultrasound of both sides of head and neck blood flow | 65 | $11,021 | $170 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 53 | $10,106 | $95 |
| New patient visit (60+ min) | 51 | $9,335 | $183 |
| Programming of dual lead pacemaker system | 80 | $7,636 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 453 | $7,346 | $15 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 214 | $6,877 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $6,533 | $91 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 76 | $6,274 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 101 | $5,896 | $56 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 30 | $5,007 | $162 |
| Ultrasound study of arm and leg arteries | 73 | $3,741 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,262 | $119 |
| Short return visit | 17 | $1,853 | $39 |
| Administration of influenza virus vaccine | 34 | $1,077 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 31 | $608 | $20 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 34 | $533 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 31 | $397 | $13 |
| Blood test, clotting time | 14 | $362 | $5 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 40 | $297 | $7 |
| Insertion of needle into vein for collection of blood sample | 14 | $203 | $3 |
2015: 32 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 168 | $244,201 | $1,436 |
| Return visit (30+ min) | 482 | $105,568 | $97 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 168 | $76,739 | $227 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 292 | $61,747 | $211 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 58 | $28,977 | $500 |
| Long return visit (40+ min) | 141 | $22,506 | $129 |
| Short return visit (20+ min) | 220 | $21,134 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 99 | $20,248 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 112 | $19,800 | $64 |
| New patient visit (45+ min) | 120 | $17,552 | $146 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 231 | $16,772 | $71 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 58 | $15,341 | $132 |
| New patient visit (60+ min) | 45 | $8,223 | $183 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 206 | $7,773 | None |
| Programming of dual lead pacemaker system | 85 | $7,648 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 438 | $7,039 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $6,777 | $56 |
| Ultrasound of both sides of head and neck blood flow | 32 | $6,171 | $193 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 72 | $5,922 | $80 |
| Ultrasound study of arm and leg arteries | 94 | $4,819 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $4,787 | $266 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,622 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,596 | $92 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 17 | $3,442 | $202 |
| Short return visit | 16 | $1,939 | $38 |
| Administration of influenza virus vaccine | 31 | $898 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 36 | $734 | $20 |
| Blood test, clotting time | 17 | $524 | $5 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 31 | $481 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 36 | $479 | $13 |
| Insertion of needle into vein for collection of blood sample | 17 | $291 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 38 | $285 | $8 |
2014: 37 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 142 | $207,050 | $1,458 |
| Return visit (30+ min) | 513 | $91,743 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 373 | $77,995 | $205 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 142 | $64,989 | $229 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 84 | $41,532 | $494 |
| Short return visit (20+ min) | 361 | $39,448 | $68 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 84 | $22,147 | $132 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 202 | $20,290 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $18,318 | $64 |
| Long return visit (40+ min) | 128 | $18,177 | $128 |
| New patient visit (45+ min) | 120 | $17,422 | $145 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 229 | $16,171 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $15,649 | $180 |
| New patient visit (60+ min) | 66 | $11,746 | $178 |
| Programming of dual lead pacemaker system | 107 | $10,282 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 166 | $9,760 | $57 |
| Ultrasound of both sides of head and neck blood flow | 46 | $8,295 | $180 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $8,008 | $445 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 36 | $6,810 | $189 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 390 | $6,357 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 65 | $5,546 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,247 | $118 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $4,195 | $262 |
| Ultrasound study of arm and leg arteries | 43 | $2,824 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,680 | $92 |
| Short return visit | 21 | $1,872 | $40 |
| Administration of influenza virus vaccine | 58 | $1,805 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 58 | $862 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 41 | $814 | $20 |
| Blood test, clotting time | 22 | $647 | $5 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 18 | $555 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 41 | $534 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $450 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 50 | $379 | $8 |
| Insertion of needle into vein for collection of blood sample | 22 | $362 | $3 |
| Injection, dipyridamole, per 10 mg | 13 | $30 | None |
| Injection, aminophyllin, up to 250 mg | 13 | $16 | None |
2013: 39 services
| Return visit (30+ min) | 583 | $118,459 | $94 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 219 | $112,617 | $514 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 219 | $57,930 | $132 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 22 | $54,931 | $1,831 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 324 | $54,543 | $166 |
| Short return visit (20+ min) | 341 | $37,084 | $67 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 211 | $36,459 | None |
| New patient visit (45+ min) | 165 | $23,528 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 144 | $19,901 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 231 | $15,730 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,606 | $176 |
| Ultrasound study of arm and leg arteries | 131 | $11,136 | $85 |
| Programming of dual lead pacemaker system | 109 | $10,587 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $9,390 | $56 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $8,851 | $443 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 476 | $8,463 | $17 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $8,228 | $119 |
| Long return visit (40+ min) | 55 | $7,643 | $130 |
| New patient visit (60+ min) | 37 | $6,484 | $175 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 74 | $6,478 | $84 |
| Ultrasound of both sides of head and neck blood flow | 34 | $6,277 | $185 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 29 | $5,812 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $4,413 | $90 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,961 | $248 |
| Administration of influenza virus vaccine | 101 | $3,245 | $32 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $2,423 | $110 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $1,904 | $20 |
| Blood test, clotting time | 35 | $1,175 | $5 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,174 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 54 | $1,040 | $19 |
| Short return visit | 18 | $802 | $36 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 51 | $717 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 54 | $689 | $13 |
| Insertion of needle into vein for collection of blood sample | 35 | $653 | $3 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 20 | $594 | $30 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 51 | $490 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 54 | $395 | $7 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $193 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $39 | $3 |
Medicaid work
$43,191 in 2024
Medicaid paid $43,191 for 3,309 billed services this clinician did in 2024, up to 194 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 490 | $22,493 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,404 | $6,203 |
| Return visit (30+ min) | 400 | $5,572 |
| Long return visit (40+ min) | 232 | $2,800 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 24 | $1,594 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 317 | $1,114 |
| Injection, regadenoson, 0.1 mg | 64 | $1,096 |
| CARDIOVASCULAR STRESS TEST | 67 | $896 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 66 | $475 |
| Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels) | 20 | $437 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 12 | $349 |
| New patient visit (45+ min) | 14 | $80 |
| 2024 | 3,309 | 17 | 194 | $43,191 |
| 2023 | 3,829 | 16 | 155 | $42,993 |
| 2022 | 2,759 | 12 | 125 | $32,427 |
| 2021 | 3,149 | 13 | 132 | $31,554 |
| 2020 | 2,314 | 13 | 87 | $20,111 |
| 2019 | 2,084 | 12 | 82 | $22,869 |
| 2018 | 1,751 | 9 | 56 | $19,695 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 635 | $25,183 |
| Return visit (30+ min) | 733 | $3,682 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 783 | $2,891 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 50 | $1,717 |
| New patient visit (45+ min) | 233 | $1,706 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 12 | $1,552 |
| Injection, regadenoson, 0.1 mg | 79 | $1,494 |
| CARDIOVASCULAR STRESS TEST | 208 | $1,126 |
| Long return visit (40+ min) | 112 | $871 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 600 | $819 |
| Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels) | 31 | $591 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 51 | $560 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 599 | $26,559 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 525 | $2,829 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 13 | $837 |
| Return visit (30+ min) | 568 | $657 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 110 | $410 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 450 | $370 |
| CARDIOVASCULAR STRESS TEST | 124 | $310 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 47 | $210 |
| New patient visit (45+ min) | 164 | $201 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 107 | $43 |
| Long return visit (40+ min) | 40 | $0 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 12 | $0 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 608 | $20,115 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 72 | $3,861 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 605 | $3,500 |
| New patient visit (45+ min) | 193 | $1,889 |
| Return visit (30+ min) | 686 | $672 |
| CARDIOVASCULAR STRESS TEST | 162 | $526 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 56 | $394 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 476 | $387 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 124 | $112 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 114 | $91 |
| Infusion, normal saline solution, 250 cc | 28 | $8 |
| Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic) | 12 | $0 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 456 | $13,216 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 313 | $1,976 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 28 | $1,031 |
| New patient visit (45+ min) | 154 | $983 |
| CARDIOVASCULAR STRESS TEST | 156 | $613 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 59 | $565 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 301 | $536 |
| Tc99m sestamibi | 12 | $487 |
| Return visit (30+ min) | 602 | $285 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 73 | $219 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 84 | $173 |
| Infusion, normal saline solution, 250 cc | 25 | $26 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 532 | $17,833 |
| DUPLEX SCAN EXTRACRANIAL ART COMPL BI STUDY | 29 | $924 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 417 | $819 |
| Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care professional; dual lead pacemaker system | 24 | $813 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 125 | $635 |
| New patient visit (45+ min) | 235 | $573 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 87 | $513 |
| CARDIOVASCULAR STRESS TEST | 221 | $504 |
| Return visit (30+ min) | 369 | $256 |
| Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic) | 14 | $0 |
| Short return visit (20+ min) | 17 | $0 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 14 | $0 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 420 | $16,664 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 391 | $1,192 |
| CARDIOVASCULAR STRESS TEST | 189 | $1,188 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 121 | $402 |
| Return visit (30+ min) | 449 | $230 |
| Myocardial imaging, positron emission tomography (PET), perfusion study (including ventricular wall motion[s] and/or ejection fraction[s], when performed); multiple studies at rest and stress (exercise or pharmacologic) | 14 | $20 |
| New patient visit (45+ min) | 123 | $0 |
| Short return visit (20+ min) | 30 | $0 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 14 | $0 |
Drugs they prescribed that Part D paid
$1,457,385
Pharmacies billed $1,457,385 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,107) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
4,576 generic and 1,531 brand-name prescriptions · $1,457,385 in drug cost · 23 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 751 | $761,202 | $1,014 |
| Xarelto | 181 | $205,612 | $1,136 |
| Entresto | 145 | $148,349 | $1,023 |
| Jardiance | 100 | $94,076 | $941 |
| Multaq | 39 | $60,729 | $1,557 |
See all 68 drugs
| Eliquis | 751 | $761,202 | $1,014 |
| Xarelto | 181 | $205,612 | $1,136 |
| Entresto | 145 | $148,349 | $1,023 |
| Jardiance | 100 | $94,076 | $941 |
| Multaq | 39 | $60,729 | $1,557 |
| Farxiga | 48 | $39,507 | $823 |
| Brilinta | 33 | $18,433 | $559 |
| Verquvo | 17 | $14,951 | $879 |
| Vascepa | 19 | $14,371 | $756 |
| Repatha Sureclick | 25 | $13,461 | $538 |
| Metoprolol | 571 | $7,338 | $13 |
| Praluent | 13 | $6,429 | $495 |
| Pradaxa | 16 | $4,866 | $304 |
| Propafenone Hcl Er | 16 | $4,454 | $278 |
| Icosapent Ethyl | 19 | $4,247 | $224 |
| Flecainide Acetate | 108 | $3,401 | $31 |
| Edarbi | 13 | $3,298 | $254 |
| Dabigatran Etexilate | 14 | $3,233 | $231 |
| Clopidogrel | 244 | $2,822 | $12 |
| Losartan | 236 | $2,521 | $11 |
| Sotalol | 193 | $2,267 | $12 |
| Carvedilol | 271 | $2,165 | $8 |
| Atorvastatin | 311 | $2,151 | $7 |
| Isosorbide Mononitrate Er | 228 | $2,089 | $9 |
| Propafenone | 76 | $1,872 | $25 |
| Amlodipine Besylate | 320 | $1,838 | $6 |
| Rosuvastatin | 142 | $1,794 | $13 |
| Potassium Chloride | 167 | $1,752 | $10 |
| Nitroglycerin | 140 | $1,651 | $12 |
| Ranolazine Er | 29 | $1,557 | $54 |
| Midodrine | 24 | $1,340 | $56 |
| Furosemide | 325 | $1,333 | $4 |
| Bumetanide | 58 | $1,219 | $21 |
| Metoprolol | 137 | $834 | $6 |
| Isosorbide Dinitrate | 35 | $780 | $22 |
| Amiodarone | 51 | $771 | $15 |
| Spironolactone | 97 | $762 | $8 |
| Eplerenone | 14 | $719 | $51 |
| Ezetimibe | 52 | $633 | $12 |
| Indapamide | 43 | $513 | $12 |
| Warfarin | 15 | $332 | $22 |
| Nifedipine Er | 15 | $312 | $21 |
| Omeprazole | 48 | $260 | $5 |
| Atenolol | 41 | $254 | $6 |
| Irbesartan | 14 | $236 | $17 |
| Losartan-Hydrochlorothiazide | 27 | $235 | $9 |
| Clonidine | 22 | $231 | $10 |
| Gabapentin | 24 | $231 | $10 |
| Simvastatin | 39 | $228 | $6 |
| Klor-Con 10 | 26 | $219 | $8 |
| Lisinopril | 33 | $203 | $6 |
| Famotidine | 33 | $201 | $6 |
| Diltiazem 24hr Er (Cd) | 19 | $194 | $10 |
| Bisoprolol | 11 | $190 | $17 |
| Tamsulosin | 19 | $186 | $10 |
| Digoxin | 12 | $185 | $15 |
| Verapamil Er | 13 | $171 | $13 |
| Propranolol | 11 | $167 | $15 |
| Mirtazapine | 21 | $115 | $5 |
| Sertraline | 16 | $102 | $6 |
| Hydrochlorothiazide | 11 | $80 | $7 |
| Folic Acid | 23 | $71 | $3 |
| Chlorthalidone | 12 | $69 | $6 |
| Sildenafil Citrate | 21 | $59 | $3 |
| Pantoprazole | 13 | $52 | $4 |
| Trazodone | 12 | $42 | $4 |
| Clindamycin | 11 | $25 | $2 |
| Metformin Hcl Er | 13 | $25 | $2 |
Year by year
| 2024 | 6,107 | 798 | 0% (0) | 25% | $1,457,385 |
| 2023 | 6,039 | 855 | 0% (0) | 25% | $1,503,671 |
| 2022 | 6,831 | 876 | None | 25% | $1,434,445 |
| 2021 | 7,331 | 835 | None | None | $1,220,807 |
| 2020 | 7,148 | 793 | None | None | $1,044,025 |
| 2019 | 6,980 | 840 | None | None | $943,932 |
| 2018 | 6,734 | 773 | 0% (12) | None | $878,222 |
| 2017 | 6,849 | 707 | 0% (16) | None | $714,262 |
| 2016 | 6,946 | 660 | 0% (12) | None | $597,775 |
| 2015 | 6,699 | 597 | 0% (22) | None | $523,897 |
| 2014 | 6,683 | 602 | 1% (45) | None | $482,165 |
| 2013 | 7,280 | 574 | 0% (31) | None | $556,863 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 62 drugs
| Eliquis | 739 | $723,175 | $979 |
| Xarelto | 222 | $255,058 | $1,149 |
| Entresto | 159 | $157,067 | $988 |
| Jardiance | 96 | $104,433 | $1,088 |
| Farxiga | 49 | $39,349 | $803 |
| Multaq | 32 | $29,506 | $922 |
| Metoprolol | 710 | $14,993 | $21 |
| Brilinta | 17 | $14,918 | $878 |
| Propafenone Hcl Er | 25 | $12,351 | $494 |
| Verquvo | 17 | $11,155 | $656 |
| Praluent | 19 | $10,331 | $544 |
| Pradaxa | 13 | $6,825 | $525 |
| Repatha Sureclick | 12 | $6,710 | $559 |
| Sotalol | 226 | $6,306 | $28 |
| Atorvastatin | 331 | $5,952 | $18 |
| Isosorbide Mononitrate Er | 259 | $5,421 | $21 |
| Losartan | 190 | $5,221 | $27 |
| Icosapent Ethyl | 13 | $5,099 | $392 |
| Amlodipine Besylate | 327 | $5,075 | $16 |
| Carvedilol | 299 | $4,764 | $16 |
| Dabigatran Etexilate | 11 | $4,714 | $429 |
| Clopidogrel | 247 | $4,654 | $19 |
| Flecainide Acetate | 58 | $4,143 | $71 |
| Ranolazine Er | 23 | $3,976 | $173 |
| Nitroglycerin | 143 | $3,309 | $23 |
| Rosuvastatin | 90 | $3,046 | $34 |
| Edarbi | 11 | $2,871 | $261 |
| Digoxin | 42 | $2,867 | $68 |
| Potassium Chloride | 128 | $2,828 | $22 |
| Propafenone | 52 | $2,491 | $48 |
| Furosemide | 284 | $1,965 | $7 |
| Indapamide | 74 | $1,491 | $20 |
| Spironolactone | 108 | $1,477 | $14 |
| Metoprolol | 120 | $1,345 | $11 |
| Midodrine | 18 | $1,174 | $65 |
| Bumetanide | 32 | $1,085 | $34 |
| Amiodarone | 50 | $995 | $20 |
| Propranolol Hcl Er | 15 | $960 | $64 |
| Isosorbide Dinitrate | 19 | $885 | $47 |
| Diltiazem 24hr Er (Cd) | 14 | $787 | $56 |
| Simvastatin | 47 | $706 | $15 |
| Atenolol | 47 | $703 | $15 |
| Lisinopril | 34 | $582 | $17 |
| Klor-Con 10 | 17 | $507 | $30 |
| Losartan-Hydrochlorothiazide | 32 | $499 | $16 |
| Labetalol | 11 | $481 | $44 |
| Albuterol Sulfate Hfa | 13 | $477 | $37 |
| Omeprazole | 51 | $470 | $9 |
| Ezetimibe | 11 | $460 | $42 |
| Tamsulosin | 19 | $448 | $24 |
| Irbesartan | 11 | $410 | $37 |
| Warfarin | 11 | $379 | $34 |
| Famotidine | 31 | $337 | $11 |
| Hydralazine | 18 | $259 | $14 |
| Sildenafil Citrate | 16 | $205 | $13 |
| Pantoprazole | 24 | $164 | $7 |
| Sertraline | 11 | $138 | $13 |
| Gabapentin | 11 | $125 | $11 |
| Clindamycin | 15 | $82 | $5 |
| Hydrochlorothiazide | 12 | $74 | $6 |
| Folic Acid | 12 | $57 | $5 |
| Metformin Hcl Er | 13 | $49 | $4 |
2022: 61 drugs
| Eliquis | 849 | $723,294 | $852 |
| Xarelto | 281 | $265,391 | $944 |
| Entresto | 146 | $130,448 | $893 |
| Jardiance | 81 | $82,488 | $1,018 |
| Pradaxa | 37 | $24,856 | $672 |
| Multaq | 16 | $20,894 | $1,306 |
| Farxiga | 32 | $20,620 | $644 |
| Brilinta | 29 | $12,919 | $445 |
| Vascepa | 19 | $12,133 | $639 |
| Metoprolol | 666 | $11,273 | $17 |
| Propafenone Hcl Er | 19 | $7,593 | $400 |
| Clopidogrel | 323 | $5,692 | $18 |
| Sotalol | 209 | $4,271 | $20 |
| Amlodipine Besylate | 368 | $4,088 | $11 |
| Carvedilol | 319 | $3,999 | $13 |
| Isosorbide Mononitrate Er | 300 | $3,977 | $13 |
| Ranolazine Er | 37 | $3,929 | $106 |
| Losartan | 260 | $3,914 | $15 |
| Atorvastatin | 348 | $3,895 | $11 |
| Potassium Chloride | 211 | $3,853 | $18 |
| Rosuvastatin | 88 | $3,797 | $43 |
| Flecainide Acetate | 66 | $3,709 | $56 |
| Propafenone | 75 | $3,257 | $43 |
| Nitroglycerin | 125 | $3,230 | $26 |
| Edarbi | 13 | $3,168 | $244 |
| Amiodarone | 44 | $2,509 | $57 |
| Furosemide | 400 | $2,069 | $5 |
| Propranolol Hcl Er | 26 | $1,905 | $73 |
| Diltiazem 24hr Er (Cd) | 59 | $1,707 | $29 |
| Indapamide | 64 | $1,444 | $23 |
| Digoxin | 63 | $1,398 | $22 |
| Spironolactone | 115 | $1,230 | $11 |
| Isosorbide Dinitrate | 15 | $947 | $63 |
| Albuterol Sulfate Hfa | 24 | $775 | $32 |
| Atenolol | 68 | $766 | $11 |
| Labetalol | 14 | $750 | $54 |
| Losartan-Hydrochlorothiazide | 38 | $644 | $17 |
| Metoprolol | 126 | $638 | $5 |
| Nifedipine Er | 16 | $603 | $38 |
| Omeprazole | 64 | $592 | $9 |
| Doxazosin Mesylate | 15 | $547 | $36 |
| Bumetanide | 16 | $529 | $33 |
| Diltiazem 24hr Er (Xr) | 13 | $496 | $38 |
| Pantoprazole | 21 | $418 | $20 |
| Mirtazapine | 27 | $379 | $14 |
| Simvastatin | 53 | $320 | $6 |
| Klor-Con 10 | 18 | $309 | $17 |
| Tamsulosin | 14 | $281 | $20 |
| Bisoprolol | 14 | $266 | $19 |
| Hydralazine | 27 | $219 | $8 |
| Famotidine | 29 | $208 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $189 | $15 |
| Gabapentin | 19 | $167 | $9 |
| Lisinopril | 28 | $156 | $6 |
| Trazodone | 11 | $149 | $14 |
| Meclizine | 12 | $132 | $11 |
| Clonidine | 23 | $128 | $6 |
| Sertraline | 16 | $109 | $7 |
| Hydrochlorothiazide | 14 | $104 | $7 |
| Sildenafil Citrate | 19 | $96 | $5 |
| Clindamycin | 14 | $57 | $4 |
2021: 66 drugs
| Eliquis | 782 | $600,809 | $768 |
| Xarelto | 346 | $276,996 | $801 |
| Entresto | 121 | $86,128 | $712 |
| Pradaxa | 45 | $32,738 | $728 |
| Jardiance | 31 | $29,386 | $948 |
| Multaq | 24 | $26,301 | $1,096 |
| Brilinta | 28 | $14,119 | $504 |
| Vascepa | 30 | $12,439 | $415 |
| Metoprolol | 668 | $10,787 | $16 |
| Propafenone Hcl Er | 23 | $8,882 | $386 |
| Atorvastatin | 422 | $4,472 | $11 |
| Sotalol | 261 | $4,168 | $16 |
| Carvedilol | 358 | $3,991 | $11 |
| Clopidogrel | 339 | $3,879 | $11 |
| Flecainide Acetate | 42 | $3,817 | $91 |
| Propafenone | 83 | $3,735 | $45 |
| Diltiazem 24hr Er (Cd) | 98 | $3,478 | $35 |
| Losartan | 272 | $3,452 | $13 |
| Potassium Chloride | 262 | $3,256 | $12 |
| Amlodipine Besylate | 427 | $3,214 | $8 |
| Isosorbide Mononitrate Er | 222 | $3,065 | $14 |
| Ranolazine Er | 33 | $2,794 | $85 |
| Amiodarone | 75 | $2,778 | $37 |
| Nitroglycerin | 95 | $2,660 | $28 |
| Rosuvastatin | 70 | $2,520 | $36 |
| Digoxin | 71 | $1,896 | $27 |
| Propranolol Hcl Er | 33 | $1,831 | $55 |
| Indapamide | 70 | $1,693 | $24 |
| Furosemide | 412 | $1,636 | $4 |
| Albuterol Sulfate Hfa | 35 | $1,365 | $39 |
| Doxazosin Mesylate | 41 | $1,295 | $32 |
| Spironolactone | 159 | $1,277 | $8 |
| Telmisartan | 15 | $1,084 | $72 |
| Losartan-Hydrochlorothiazide | 62 | $987 | $16 |
| Metoprolol | 138 | $663 | $5 |
| Bumetanide | 13 | $610 | $47 |
| Labetalol | 14 | $585 | $42 |
| Midodrine | 13 | $575 | $44 |
| Atenolol | 87 | $533 | $6 |
| Omeprazole | 80 | $524 | $7 |
| Klor-Con 10 | 29 | $502 | $17 |
| Nifedipine Er | 21 | $472 | $22 |
| Bisoprolol | 15 | $470 | $31 |
| Simvastatin | 65 | $413 | $6 |
| Dilt-Xr | 11 | $402 | $37 |
| Pantoprazole | 31 | $390 | $13 |
| Gabapentin | 55 | $348 | $6 |
| Hydralazine | 20 | $296 | $15 |
| Famotidine | 31 | $264 | $9 |
| Propranolol | 11 | $259 | $24 |
| Warfarin | 19 | $231 | $12 |
| Valsartan-Hydrochlorothiazide | 12 | $219 | $18 |
| Lisinopril | 36 | $213 | $6 |
| Levothyroxine | 15 | $213 | $14 |
| Ondansetron | 11 | $209 | $19 |
| Trazodone | 31 | $205 | $7 |
| Tamsulosin | 16 | $199 | $12 |
| Digox | 17 | $194 | $11 |
| Pravastatin | 11 | $169 | $15 |
| Lisinopril-Hydrochlorothiazide | 13 | $145 | $11 |
| Escitalopram | 13 | $134 | $10 |
| Hydrochlorothiazide | 13 | $89 | $7 |
| Meclizine | 11 | $89 | $8 |
| Clonidine | 13 | $74 | $6 |
| Clindamycin | 19 | $59 | $3 |
| Metformin | 11 | $10 | $1 |
2020: 69 drugs
| Eliquis | 632 | $483,865 | $766 |
| Xarelto | 315 | $261,728 | $831 |
| Entresto | 76 | $53,177 | $700 |
| Pradaxa | 59 | $43,877 | $744 |
| Jardiance | 26 | $17,839 | $686 |
| Propafenone Hcl Er | 23 | $13,911 | $605 |
| Metoprolol | 750 | $11,910 | $16 |
| Brilinta | 22 | $11,111 | $505 |
| Ranexa | 12 | $9,270 | $772 |
| Flecainide Acetate | 55 | $4,647 | $84 |
| Losartan-Hydrochlorothiazide | 51 | $4,458 | $87 |
| Sotalol | 283 | $4,326 | $15 |
| Vascepa | 12 | $4,016 | $335 |
| Rosuvastatin | 81 | $3,909 | $48 |
| Amiodarone | 72 | $3,464 | $48 |
| Atorvastatin | 372 | $3,393 | $9 |
| Losartan | 297 | $3,332 | $11 |
| Carvedilol | 411 | $3,326 | $8 |
| Propafenone | 80 | $3,250 | $41 |
| Clopidogrel | 371 | $3,228 | $9 |
| Nitroglycerin | 104 | $3,148 | $30 |
| Digoxin | 53 | $2,988 | $56 |
| Ranolazine Er | 33 | $2,774 | $84 |
| Potassium Chloride | 164 | $2,589 | $16 |
| Indapamide | 151 | $2,523 | $17 |
| Isosorbide Mononitrate Er | 188 | $2,408 | $13 |
| Diltiazem 24hr Er (Cd) | 69 | $2,389 | $35 |
| Amlodipine Besylate | 362 | $2,095 | $6 |
| Furosemide | 363 | $1,631 | $4 |
| Doxazosin Mesylate | 60 | $1,578 | $26 |
| Midodrine | 14 | $1,153 | $82 |
| Olmesartan Medoxomil | 12 | $1,145 | $95 |
| Digox | 24 | $1,093 | $46 |
| Ventolin Hfa | 18 | $1,038 | $58 |
| Albuterol Sulfate Hfa | 21 | $935 | $45 |
| Valsartan | 13 | $905 | $70 |
| Telmisartan | 12 | $855 | $71 |
| Spironolactone | 138 | $821 | $6 |
| Bisoprolol | 24 | $735 | $31 |
| Metoprolol | 118 | $710 | $6 |
| Isosorbide Dinitrate | 17 | $687 | $40 |
| Diltiazem 24hr Er | 18 | $631 | $35 |
| Irbesartan | 24 | $626 | $26 |
| Pantoprazole | 84 | $573 | $7 |
| Atenolol | 85 | $534 | $6 |
| Labetalol | 21 | $516 | $25 |
| Levothyroxine | 26 | $487 | $19 |
| Ondansetron | 12 | $423 | $35 |
| Diclofenac | 12 | $405 | $34 |
| Warfarin | 15 | $376 | $25 |
| Omeprazole | 53 | $365 | $7 |
| Lisinopril | 62 | $357 | $6 |
| Propranolol | 17 | $357 | $21 |
| Gabapentin | 49 | $319 | $7 |
| Ezetimibe | 13 | $315 | $24 |
| Pravastatin | 21 | $302 | $14 |
| Simvastatin | 69 | $290 | $4 |
| Allopurinol | 22 | $275 | $12 |
| Klor-Con 10 | 13 | $223 | $17 |
| Famotidine | 22 | $197 | $9 |
| Tamsulosin | 14 | $154 | $11 |
| Hydralazine | 19 | $147 | $8 |
| Hydrochlorothiazide | 19 | $146 | $8 |
| Trazodone | 26 | $135 | $5 |
| Cartia Xt | 11 | $112 | $10 |
| Lisinopril-Hydrochlorothiazide | 15 | $97 | $6 |
| Clonidine | 17 | $88 | $5 |
| Clindamycin | 18 | $57 | $3 |
| Lorazepam | 14 | $54 | $4 |
2019: 69 drugs
| Eliquis | 593 | $414,729 | $699 |
| Xarelto | 305 | $236,586 | $776 |
| Pradaxa | 58 | $38,808 | $669 |
| Entresto | 59 | $34,365 | $582 |
| Multaq | 18 | $22,552 | $1,253 |
| Propafenone Hcl Er | 32 | $18,315 | $572 |
| Metoprolol | 736 | $17,036 | $23 |
| Ranexa | 14 | $11,416 | $815 |
| Brilinta | 27 | $11,066 | $410 |
| Jardiance | 16 | $8,995 | $562 |
| Sotalol | 276 | $4,625 | $17 |
| Carvedilol | 461 | $4,536 | $10 |
| Atorvastatin | 365 | $4,377 | $12 |
| Nitroglycerin | 119 | $4,311 | $36 |
| Vascepa | 12 | $3,903 | $325 |
| Ranolazine Er | 13 | $3,860 | $297 |
| Clopidogrel | 340 | $3,603 | $11 |
| Amiodarone | 106 | $3,150 | $30 |
| Losartan | 325 | $2,953 | $9 |
| Potassium Chloride | 164 | $2,922 | $18 |
| Flecainide Acetate | 40 | $2,797 | $70 |
| Edarbi | 13 | $2,635 | $203 |
| Amlodipine Besylate | 399 | $2,573 | $6 |
| Digoxin | 38 | $2,481 | $65 |
| Diltiazem 24hr Er (Cd) | 69 | $2,478 | $36 |
| Isosorbide Mononitrate Er | 168 | $2,420 | $14 |
| Doxazosin Mesylate | 75 | $2,104 | $28 |
| Telmisartan | 11 | $1,986 | $181 |
| Digox | 43 | $1,776 | $41 |
| Olmesartan Medoxomil | 31 | $1,736 | $56 |
| Propafenone | 25 | $1,708 | $68 |
| Indapamide | 112 | $1,678 | $15 |
| Furosemide | 377 | $1,613 | $4 |
| Ventolin Hfa | 22 | $1,345 | $61 |
| Bisoprolol | 33 | $1,119 | $34 |
| Olmesartan-Hydrochlorothiazide | 15 | $969 | $65 |
| Diltiazem 24hr Er | 18 | $918 | $51 |
| Albuterol Sulfate Hfa | 15 | $872 | $58 |
| Levothyroxine | 32 | $853 | $27 |
| Rosuvastatin | 18 | $730 | $41 |
| Pantoprazole | 88 | $722 | $8 |
| Mirtazapine | 23 | $721 | $31 |
| Pravastatin | 29 | $707 | $24 |
| Warfarin | 21 | $702 | $33 |
| Spironolactone | 116 | $650 | $6 |
| Valsartan | 14 | $631 | $45 |
| Losartan-Hydrochlorothiazide | 53 | $621 | $12 |
| Isosorbide Dinitrate | 16 | $606 | $38 |
| Atenolol | 92 | $589 | $6 |
| Simvastatin | 78 | $557 | $7 |
| Labetalol | 19 | $490 | $26 |
| Allopurinol | 11 | $437 | $40 |
| Metoprolol | 74 | $425 | $6 |
| Cartia Xt | 12 | $419 | $35 |
| Omeprazole | 44 | $386 | $9 |
| Ranitidine | 44 | $369 | $8 |
| Lisinopril | 56 | $361 | $6 |
| Klor-Con 10 | 14 | $301 | $22 |
| Irbesartan | 17 | $216 | $13 |
| Alendronate | 17 | $213 | $13 |
| Gabapentin | 32 | $186 | $6 |
| Tamsulosin | 13 | $172 | $13 |
| Hydrochlorothiazide | 25 | $167 | $7 |
| Amlodipine Besylate-Benazepril | 11 | $147 | $13 |
| Meclizine | 13 | $101 | $8 |
| Metformin | 15 | $94 | $6 |
| Glipizide | 12 | $82 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $66 | $6 |
| Lorazepam | 11 | $61 | $6 |
2018: 68 drugs
| Eliquis | 622 | $359,912 | $579 |
| Xarelto | 308 | $226,128 | $734 |
| Pradaxa | 54 | $37,339 | $691 |
| Propafenone Hcl Er | 31 | $21,159 | $683 |
| Ranexa | 32 | $17,997 | $562 |
| Metoprolol | 643 | $15,257 | $24 |
| Brilinta | 36 | $13,897 | $386 |
| Multaq | 20 | $13,752 | $688 |
| Entresto | 13 | $9,425 | $725 |
| Atorvastatin | 339 | $4,917 | $15 |
| Symbicort | 15 | $4,859 | $324 |
| Nitroglycerin | 124 | $4,385 | $35 |
| Carvedilol | 464 | $4,319 | $9 |
| Ventolin Hfa | 70 | $4,083 | $58 |
| Clopidogrel | 342 | $4,039 | $12 |
| Flecainide Acetate | 27 | $3,943 | $146 |
| Amiodarone | 138 | $3,209 | $23 |
| Losartan | 322 | $3,079 | $10 |
| Digoxin | 49 | $3,056 | $62 |
| Sotalol | 173 | $2,764 | $16 |
| Isosorbide Mononitrate Er | 162 | $2,522 | $16 |
| Amlodipine Besylate | 368 | $2,449 | $7 |
| Ezetimibe | 15 | $2,382 | $159 |
| Diltiazem 24hr Er (Cd) | 86 | $2,354 | $27 |
| Edarbi | 12 | $2,295 | $191 |
| Potassium Chloride | 153 | $2,204 | $14 |
| Digox | 43 | $2,129 | $50 |
| Olmesartan Medoxomil | 26 | $1,430 | $55 |
| Valsartan | 37 | $1,425 | $39 |
| Bisoprolol | 52 | $1,410 | $27 |
| Propafenone | 36 | $1,406 | $39 |
| Doxazosin Mesylate | 56 | $1,395 | $25 |
| Furosemide | 290 | $1,228 | $4 |
| Memantine | 13 | $1,128 | $87 |
| Mirtazapine | 23 | $1,085 | $47 |
| Pravastatin | 45 | $1,012 | $22 |
| Warfarin | 45 | $1,004 | $22 |
| Indapamide | 56 | $907 | $16 |
| Levothyroxine | 37 | $837 | $23 |
| Spironolactone | 103 | $757 | $7 |
| Simvastatin | 83 | $590 | $7 |
| Omeprazole | 88 | $589 | $7 |
| Metoprolol | 94 | $576 | $6 |
| Rosuvastatin | 11 | $570 | $52 |
| Ranitidine | 55 | $552 | $10 |
| Losartan-Hydrochlorothiazide | 53 | $540 | $10 |
| Amlodipine-Valsartan | 11 | $487 | $44 |
| Atenolol | 60 | $467 | $8 |
| Chlorthalidone | 20 | $462 | $23 |
| Allopurinol | 20 | $412 | $21 |
| Triamcinolone Acetonide | 22 | $390 | $18 |
| Verapamil Er | 15 | $363 | $24 |
| Valsartan-Hydrochlorothiazide | 13 | $355 | $27 |
| Pantoprazole | 30 | $300 | $10 |
| Labetalol | 11 | $286 | $26 |
| Metolazone | 12 | $269 | $22 |
| Lisinopril | 54 | $263 | $5 |
| Klor-Con 10 | 11 | $256 | $23 |
| Gabapentin | 24 | $231 | $10 |
| Lorazepam | 19 | $189 | $10 |
| Azithromycin | 24 | $164 | $7 |
| Zolpidem | 18 | $142 | $8 |
| Alendronate | 15 | $140 | $9 |
| Metformin | 13 | $109 | $8 |
| Hydrochlorothiazide | 15 | $90 | $6 |
| Clindamycin | 11 | $74 | $7 |
| Clonidine | 14 | $67 | $5 |
| Glipizide | 13 | $63 | $5 |
2017: 82 drugs
| Eliquis | 470 | $226,050 | $481 |
| Xarelto | 342 | $196,407 | $574 |
| Pradaxa | 65 | $39,293 | $605 |
| Propafenone Hcl Er | 46 | $32,085 | $697 |
| Ranexa | 60 | $27,932 | $466 |
| Multaq | 25 | $18,253 | $730 |
| Metoprolol | 608 | $13,431 | $22 |
| Januvia | 14 | $13,016 | $930 |
| Brilinta | 24 | $9,324 | $389 |
| Symbicort | 24 | $6,991 | $291 |
| Advair Hfa | 11 | $5,250 | $477 |
| Benicar | 14 | $5,043 | $360 |
| Atorvastatin | 294 | $3,886 | $13 |
| Nitroglycerin | 96 | $3,624 | $38 |
| Zetia | 11 | $3,335 | $303 |
| Amiodarone | 163 | $3,320 | $20 |
| Clopidogrel | 362 | $3,249 | $9 |
| Carvedilol | 444 | $3,225 | $7 |
| Sotalol | 242 | $3,187 | $13 |
| Flecainide Acetate | 37 | $3,131 | $85 |
| Digoxin | 38 | $3,036 | $80 |
| Digox | 64 | $2,978 | $47 |
| Losartan | 336 | $2,947 | $9 |
| Diovan | 13 | $2,943 | $226 |
| Isosorbide Mononitrate Er | 187 | $2,886 | $15 |
| Olmesartan Medoxomil | 16 | $2,804 | $175 |
| Diltiazem 12hr Er | 19 | $2,357 | $124 |
| Edarbi | 12 | $2,219 | $185 |
| Valsartan | 48 | $1,980 | $41 |
| Amlodipine Besylate | 348 | $1,779 | $5 |
| Potassium Chloride | 97 | $1,756 | $18 |
| Diltiazem 24hr Er | 72 | $1,688 | $23 |
| Bisoprolol | 63 | $1,598 | $25 |
| Proair Hfa | 21 | $1,401 | $67 |
| Ventolin Hfa | 24 | $1,385 | $58 |
| Propafenone | 31 | $1,296 | $42 |
| Pravastatin | 64 | $1,247 | $19 |
| Furosemide | 295 | $999 | $3 |
| Doxazosin Mesylate | 31 | $929 | $30 |
| Rosuvastatin | 19 | $927 | $49 |
| Amlodipine-Valsartan | 17 | $922 | $54 |
| Losartan-Hydrochlorothiazide | 94 | $903 | $10 |
| Warfarin | 63 | $891 | $14 |
| Simvastatin | 102 | $785 | $8 |
| Valsartan-Hydrochlorothiazide | 42 | $769 | $18 |
| Levothyroxine | 28 | $749 | $27 |
| Spironolactone | 113 | $745 | $7 |
| Sotalol Af | 12 | $724 | $60 |
| Nifedipine Er | 22 | $695 | $32 |
| Omeprazole | 107 | $690 | $6 |
| Diltiazem 24hr Cd | 24 | $548 | $23 |
| Indapamide | 38 | $493 | $13 |
| Allopurinol | 22 | $449 | $20 |
| Metoprolol | 86 | $422 | $5 |
| Atenolol | 64 | $407 | $6 |
| Gabapentin | 62 | $363 | $6 |
| Klor-Con 10 | 13 | $361 | $28 |
| Chlorthalidone | 12 | $345 | $29 |
| Polyethylene Glycol 3350 | 17 | $331 | $19 |
| Metolazone | 11 | $327 | $30 |
| Ranitidine | 27 | $322 | $12 |
| Pantoprazole | 33 | $261 | $8 |
| Lisinopril | 45 | $242 | $5 |
| Donepezil | 18 | $190 | $11 |
| Tamsulosin | 11 | $184 | $17 |
| Bupropion Hcl Sr | 11 | $156 | $14 |
| Hydrochlorothiazide | 25 | $153 | $6 |
| Pioglitazone | 13 | $134 | $10 |
| Hydralazine | 11 | $119 | $11 |
| Mirtazapine | 22 | $118 | $5 |
| Acetaminophen-Codeine | 14 | $115 | $8 |
| Famotidine | 32 | $113 | $4 |
| Azithromycin | 20 | $112 | $6 |
| Alendronate | 15 | $111 | $7 |
| Meclizine | 13 | $104 | $8 |
| Montelukast | 12 | $96 | $8 |
| Metformin | 14 | $84 | $6 |
| Alprazolam | 16 | $78 | $5 |
| Lorazepam | 15 | $65 | $4 |
| Zolpidem | 13 | $53 | $4 |
| Glipizide | 14 | $50 | $4 |
| Citalopram Hbr | 21 | $45 | $2 |
2016: 83 drugs
| Xarelto | 340 | $155,892 | $459 |
| Eliquis | 351 | $142,429 | $406 |
| Pradaxa | 94 | $43,002 | $457 |
| Propafenone Hcl Er | 38 | $25,762 | $678 |
| Ranexa | 44 | $23,924 | $544 |
| Metoprolol | 712 | $16,397 | $23 |
| Januvia | 25 | $12,876 | $515 |
| Rythmol Sr | 12 | $7,683 | $640 |
| Brilinta | 22 | $7,371 | $335 |
| Benicar | 14 | $6,191 | $442 |
| Multaq | 11 | $6,162 | $560 |
| Symbicort | 21 | $5,892 | $281 |
| Namenda | 12 | $4,580 | $382 |
| Atorvastatin | 334 | $4,500 | $13 |
| Valsartan | 64 | $4,498 | $70 |
| Digox | 95 | $4,144 | $44 |
| Clopidogrel | 343 | $4,020 | $12 |
| Raloxifene | 20 | $3,877 | $194 |
| Zetia | 13 | $3,632 | $279 |
| Isosorbide Mononitrate Er | 234 | $3,623 | $15 |
| Carvedilol | 388 | $2,913 | $8 |
| Colcrys | 12 | $2,874 | $239 |
| Propafenone | 31 | $2,867 | $92 |
| Nitrostat | 78 | $2,835 | $36 |
| Losartan | 333 | $2,828 | $8 |
| Vascepa | 13 | $2,731 | $210 |
| Potassium Chloride | 124 | $2,723 | $22 |
| Amiodarone | 164 | $2,578 | $16 |
| Diovan | 13 | $2,554 | $196 |
| Digoxin | 47 | $2,550 | $54 |
| Bisoprolol | 111 | $2,049 | $18 |
| Memantine | 12 | $2,038 | $170 |
| Sotalol | 149 | $1,793 | $12 |
| Diltiazem 12hr Er | 17 | $1,730 | $102 |
| Amlodipine Besylate | 380 | $1,729 | $5 |
| Pravastatin | 63 | $1,620 | $26 |
| Proair Hfa | 25 | $1,571 | $63 |
| Valsartan-Hydrochlorothiazide | 46 | $1,470 | $32 |
| Nitroglycerin | 29 | $1,455 | $50 |
| Diltiazem 24hr Cd | 54 | $1,283 | $24 |
| Simvastatin | 168 | $1,115 | $7 |
| Omega-3 Acid Ethyl Esters | 12 | $1,076 | $90 |
| Nifedipine Er | 36 | $1,049 | $29 |
| Levothyroxine | 38 | $901 | $24 |
| Flecainide Acetate | 21 | $888 | $42 |
| Celecoxib | 11 | $881 | $80 |
| Losartan-Hydrochlorothiazide | 75 | $853 | $11 |
| Warfarin | 74 | $851 | $12 |
| Doxazosin Mesylate | 19 | $811 | $43 |
| Omeprazole | 105 | $790 | $8 |
| Furosemide | 243 | $789 | $3 |
| Allopurinol | 40 | $760 | $19 |
| Diltiazem 24hr Er | 19 | $619 | $33 |
| Mexiletine | 11 | $560 | $51 |
| Propranolol Hcl Er | 11 | $556 | $51 |
| Tamsulosin | 21 | $555 | $26 |
| Atenolol | 81 | $549 | $7 |
| Voltaren | 11 | $542 | $49 |
| Metolazone | 19 | $532 | $28 |
| Metoprolol | 81 | $493 | $6 |
| Fenofibrate | 11 | $490 | $45 |
| Spironolactone | 67 | $472 | $7 |
| Pantoprazole | 43 | $360 | $8 |
| Triamcinolone Acetonide | 19 | $347 | $18 |
| Lovastatin | 17 | $330 | $19 |
| Gabapentin | 45 | $297 | $7 |
| Ranitidine | 21 | $266 | $13 |
| Indapamide | 19 | $251 | $13 |
| Donepezil | 25 | $244 | $10 |
| Hydrochlorothiazide | 40 | $243 | $6 |
| Lisinopril | 37 | $228 | $6 |
| Famotidine | 29 | $161 | $6 |
| Alendronate | 14 | $145 | $10 |
| Montelukast | 19 | $144 | $8 |
| Benazepril | 14 | $136 | $10 |
| Azithromycin | 16 | $126 | $8 |
| Acetaminophen-Codeine | 12 | $107 | $9 |
| Metformin | 13 | $102 | $8 |
| Mirtazapine | 19 | $102 | $5 |
| Lorazepam | 22 | $84 | $4 |
| Zolpidem | 25 | $83 | $3 |
| Glipizide | 18 | $50 | $3 |
| Alprazolam | 12 | $33 | $3 |
2015: 81 drugs
| Xarelto | 296 | $119,289 | $403 |
| Eliquis | 285 | $99,418 | $349 |
| Pradaxa | 117 | $46,408 | $397 |
| Propafenone Hcl Er | 35 | $23,154 | $662 |
| Januvia | 46 | $18,235 | $396 |
| Multaq | 27 | $14,473 | $536 |
| Metoprolol | 613 | $14,454 | $24 |
| Brilinta | 38 | $11,906 | $313 |
| Ranexa | 18 | $9,300 | $517 |
| Namenda | 20 | $8,643 | $432 |
| Valsartan | 88 | $8,045 | $91 |
| Benicar | 16 | $6,375 | $398 |
| Rythmol Sr | 11 | $5,873 | $534 |
| Advair Diskus | 15 | $5,425 | $362 |
| Raloxifene | 29 | $5,244 | $181 |
| Digox | 101 | $4,751 | $47 |
| Atorvastatin | 307 | $4,424 | $14 |
| Clopidogrel | 399 | $4,111 | $10 |
| Isosorbide Mononitrate Er | 272 | $3,890 | $14 |
| Benicar Hct | 11 | $3,616 | $329 |
| Digoxin | 67 | $3,553 | $53 |
| Spiriva | 11 | $3,381 | $307 |
| Propafenone | 53 | $3,355 | $63 |
| Zetia | 14 | $3,228 | $231 |
| Nitrostat | 91 | $2,681 | $29 |
| Vascepa | 13 | $2,666 | $205 |
| Carvedilol | 326 | $2,543 | $8 |
| Diovan | 14 | $2,528 | $181 |
| Potassium Chloride | 137 | $2,501 | $18 |
| Losartan | 299 | $2,362 | $8 |
| Proair Hfa | 40 | $2,233 | $56 |
| Amiodarone | 178 | $1,999 | $11 |
| Omega-3 Acid Ethyl Esters | 11 | $1,904 | $173 |
| Pravastatin | 58 | $1,886 | $33 |
| Nifedipine Er | 51 | $1,629 | $32 |
| Amlodipine Besylate | 327 | $1,615 | $5 |
| Isosorbide Dinitrate | 16 | $1,503 | $94 |
| Diltiazem 24hr Cd | 45 | $1,430 | $32 |
| Sotalol | 126 | $1,348 | $11 |
| Doxazosin Mesylate | 42 | $1,261 | $30 |
| Simvastatin | 164 | $1,246 | $8 |
| Levothyroxine | 59 | $1,234 | $21 |
| Warfarin | 68 | $1,180 | $17 |
| Voltaren | 13 | $1,011 | $78 |
| Valsartan-Hydrochlorothiazide | 35 | $938 | $27 |
| Omeprazole | 90 | $885 | $10 |
| Allopurinol | 46 | $807 | $18 |
| Tamsulosin | 19 | $767 | $40 |
| Triamcinolone Acetonide | 25 | $653 | $26 |
| Atenolol | 97 | $645 | $7 |
| Losartan-Hydrochlorothiazide | 52 | $605 | $12 |
| Diltiazem 24hr Er | 17 | $561 | $33 |
| Furosemide | 182 | $517 | $3 |
| Metolazone | 13 | $517 | $40 |
| Bisoprolol | 23 | $497 | $22 |
| Diltiazem Er | 16 | $496 | $31 |
| Gabapentin | 55 | $474 | $9 |
| Metoprolol | 88 | $467 | $5 |
| Flecainide Acetate | 11 | $448 | $41 |
| Donepezil | 42 | $416 | $10 |
| Spironolactone | 51 | $302 | $6 |
| Alendronate | 26 | $283 | $11 |
| Hydrochlorothiazide | 47 | $277 | $6 |
| Pantoprazole | 21 | $260 | $12 |
| Zolpidem | 42 | $208 | $5 |
| Polyethylene Glycol 3350 | 15 | $206 | $14 |
| Lisinopril | 37 | $195 | $5 |
| Cilostazol | 13 | $188 | $14 |
| Clonidine | 23 | $163 | $7 |
| Azithromycin | 26 | $156 | $6 |
| Ranitidine | 23 | $154 | $7 |
| Famotidine | 20 | $129 | $6 |
| Acetaminophen-Codeine | 19 | $127 | $7 |
| Lorazepam | 35 | $119 | $3 |
| Meclizine | 12 | $108 | $9 |
| Glipizide | 25 | $94 | $4 |
| Pioglitazone | 12 | $81 | $7 |
| Metformin | 18 | $69 | $4 |
| Temazepam | 11 | $62 | $6 |
| Metformin Hcl Er | 13 | $53 | $4 |
| Alprazolam | 12 | $33 | $3 |
2014: 82 drugs
| Xarelto | 305 | $100,103 | $328 |
| Pradaxa | 140 | $47,155 | $337 |
| Eliquis | 131 | $39,821 | $304 |
| Propafenone Hcl Er | 54 | $30,210 | $559 |
| Diovan | 116 | $27,013 | $233 |
| Multaq | 34 | $15,595 | $459 |
| Metoprolol | 453 | $14,125 | $31 |
| Januvia | 35 | $12,726 | $364 |
| Namenda | 31 | $11,771 | $380 |
| Ranexa | 26 | $10,633 | $409 |
| Digox | 118 | $6,322 | $54 |
| Clopidogrel | 386 | $6,166 | $16 |
| Lovaza | 22 | $5,654 | $257 |
| Rythmol Sr | 12 | $5,210 | $434 |
| Atorvastatin | 261 | $4,878 | $19 |
| Spiriva | 16 | $4,650 | $291 |
| Carvedilol | 374 | $4,120 | $11 |
| Isosorbide Mononitrate Er | 248 | $3,937 | $16 |
| Advair Diskus | 11 | $3,773 | $343 |
| Exelon | 11 | $3,750 | $341 |
| Valsartan-Hydrochlorothiazide | 62 | $3,739 | $60 |
| Lantus Solostar | 11 | $3,645 | $331 |
| Evista | 13 | $3,402 | $262 |
| Raloxifene | 12 | $3,338 | $278 |
| Losartan | 231 | $2,745 | $12 |
| Digoxin | 59 | $2,722 | $46 |
| Nitrostat | 108 | $2,624 | $24 |
| Niacin Er | 15 | $2,576 | $172 |
| Amiodarone | 182 | $2,517 | $14 |
| Exforge | 11 | $2,307 | $210 |
| Potassium Chloride | 108 | $2,273 | $21 |
| Nifedipine Er | 57 | $2,206 | $39 |
| Colcrys | 14 | $2,131 | $152 |
| Fenofibrate | 12 | $2,105 | $175 |
| Propafenone | 38 | $2,078 | $55 |
| Proair Hfa | 42 | $2,067 | $49 |
| Amlodipine Besylate | 310 | $2,057 | $7 |
| Simvastatin | 238 | $1,957 | $8 |
| Doxazosin Mesylate | 58 | $1,892 | $33 |
| Omeprazole | 143 | $1,545 | $11 |
| Diltiazem Er | 30 | $1,494 | $50 |
| Lanoxin | 16 | $1,473 | $92 |
| Triamcinolone Acetonide | 47 | $1,367 | $29 |
| Diltiazem 24hr Cd | 25 | $1,241 | $50 |
| Zolpidem | 107 | $1,200 | $11 |
| Pravastatin | 29 | $1,162 | $40 |
| Donepezil | 54 | $1,100 | $20 |
| Levothyroxine | 46 | $1,088 | $24 |
| Sotalol | 98 | $1,085 | $11 |
| Warfarin | 77 | $1,039 | $13 |
| Diltiazem 24hr Er | 27 | $1,006 | $37 |
| Losartan-Hydrochlorothiazide | 67 | $989 | $15 |
| Tamsulosin | 31 | $901 | $29 |
| Alendronate | 55 | $646 | $12 |
| Atenolol | 90 | $637 | $7 |
| Metoprolol | 100 | $593 | $6 |
| Meclizine | 29 | $571 | $20 |
| Nifedical Xl | 19 | $565 | $30 |
| Furosemide | 166 | $559 | $3 |
| Spironolactone | 63 | $519 | $8 |
| Metolazone | 17 | $481 | $28 |
| Flecainide Acetate | 13 | $453 | $35 |
| Allopurinol | 52 | $403 | $8 |
| Hydrochlorothiazide | 48 | $363 | $8 |
| Acetaminophen-Codeine | 37 | $313 | $8 |
| Famotidine | 42 | $300 | $7 |
| Glipizide | 29 | $246 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $236 | $16 |
| Klor-Con 10 | 15 | $219 | $15 |
| Azithromycin | 30 | $217 | $7 |
| Ranitidine | 25 | $206 | $8 |
| Lisinopril | 29 | $200 | $7 |
| Escitalopram | 16 | $196 | $12 |
| Gabapentin | 21 | $166 | $8 |
| Pantoprazole | 12 | $141 | $12 |
| Lisinopril-Hydrochlorothiazide | 11 | $133 | $12 |
| Cephalexin | 24 | $127 | $5 |
| Lorazepam | 25 | $124 | $5 |
| Sotalol Af | 13 | $118 | $9 |
| Temazepam | 20 | $117 | $6 |
| Metformin | 15 | $109 | $7 |
| Clonidine | 13 | $76 | $6 |
2013: 93 drugs
| Xarelto | 337 | $95,236 | $283 |
| Pradaxa | 163 | $43,447 | $267 |
| Diovan | 163 | $40,902 | $251 |
| Propafenone | 93 | $40,765 | $438 |
| Clopidogrel | 427 | $38,279 | $90 |
| Metoprolol | 478 | $17,056 | $36 |
| Namenda | 50 | $14,911 | $298 |
| Evista | 47 | $14,329 | $305 |
| Januvia | 40 | $13,172 | $329 |
| Effient | 26 | $9,533 | $367 |
| Nexium | 38 | $8,594 | $226 |
| Atorvastatin | 227 | $8,135 | $36 |
| Spiriva | 25 | $7,801 | $312 |
| Ranexa | 19 | $7,676 | $404 |
| Multaq | 18 | $7,573 | $421 |
| Lovaza | 29 | $7,284 | $251 |
| Creon | 20 | $7,025 | $351 |
| Valsartan-Hydrochlorothiazide | 69 | $6,870 | $100 |
| Diovan Hct | 28 | $6,759 | $241 |
| Rythmol Sr | 17 | $6,280 | $369 |
| Isosorbide Mononitrate Er | 280 | $5,709 | $20 |
| Niaspan | 25 | $4,965 | $199 |
| Losartan | 194 | $4,435 | $23 |
| Exelon | 14 | $4,324 | $309 |
| Colcrys | 20 | $4,160 | $208 |
| Carvedilol | 281 | $3,993 | $14 |
| Amlodipine Besylate | 387 | $3,970 | $10 |
| Advair Diskus | 11 | $3,968 | $361 |
| Lantus Solostar | 14 | $3,715 | $265 |
| Celebrex | 16 | $3,634 | $227 |
| Diltiazem Er | 72 | $3,398 | $47 |
| Simvastatin | 310 | $3,384 | $11 |
| Pioglitazone | 15 | $2,978 | $199 |
| Escitalopram | 13 | $2,884 | $222 |
| Nifedipine Er | 70 | $2,795 | $40 |
| Proair Hfa | 48 | $2,529 | $53 |
| Potassium Chloride | 100 | $2,320 | $23 |
| Amiodarone | 139 | $2,088 | $15 |
| Midodrine | 14 | $2,024 | $145 |
| Omeprazole | 114 | $1,983 | $17 |
| Nitrostat | 81 | $1,784 | $22 |
| Digox | 142 | $1,654 | $12 |
| Warfarin | 119 | $1,630 | $14 |
| Donepezil | 64 | $1,520 | $24 |
| Sotalol | 92 | $1,495 | $16 |
| Nifedical Xl | 51 | $1,493 | $29 |
| Losartan-Hydrochlorothiazide | 78 | $1,479 | $19 |
| Doxazosin Mesylate | 79 | $1,364 | $17 |
| Diltiazem 24hr Er | 38 | $1,312 | $35 |
| Spironolactone | 95 | $1,214 | $13 |
| Alendronate | 71 | $1,168 | $16 |
| Tamsulosin | 49 | $993 | $20 |
| Pravastatin | 35 | $896 | $26 |
| Famciclovir | 15 | $848 | $57 |
| Metoprolol | 128 | $847 | $7 |
| Bystolic | 11 | $820 | $75 |
| Meclizine | 45 | $804 | $18 |
| Levothyroxine | 53 | $728 | $14 |
| Furosemide | 161 | $708 | $4 |
| Zolpidem | 121 | $670 | $6 |
| Hydrochlorothiazide | 48 | $553 | $12 |
| Triamcinolone Acetonide | 30 | $540 | $18 |
| Atenolol | 84 | $524 | $6 |
| Famotidine | 62 | $471 | $8 |
| Fluticasone Propionate | 17 | $458 | $27 |
| Ranitidine | 40 | $425 | $11 |
| Glyburide-Metformin | 19 | $406 | $21 |
| Polyethylene Glycol 3350 | 14 | $386 | $28 |
| Digoxin | 36 | $382 | $11 |
| Gabapentin | 36 | $343 | $10 |
| Azithromycin | 36 | $338 | $9 |
| Flecainide Acetate | 14 | $323 | $23 |
| Klor-Con 10 | 18 | $285 | $16 |
| Pantoprazole | 15 | $274 | $18 |
| Lisinopril | 39 | $274 | $7 |
| Acetaminophen-Codeine | 31 | $270 | $9 |
| Nitroglycerin Patch | 14 | $267 | $19 |
| Metformin | 27 | $261 | $10 |
| Triamterene-Hctz | 11 | $242 | $22 |
| Glyburide | 14 | $223 | $16 |
| Metolazone | 11 | $219 | $20 |
| Glimepiride | 27 | $219 | $8 |
| Methimazole | 12 | $212 | $18 |
| Benazepril | 24 | $196 | $8 |
| Allopurinol | 21 | $194 | $9 |
| Mirtazapine | 16 | $178 | $11 |
| Glipizide | 19 | $156 | $8 |
| Paroxetine | 11 | $140 | $13 |
| Diltiazem | 14 | $129 | $9 |
| Cephalexin | 17 | $123 | $7 |
| Meloxicam | 14 | $104 | $7 |
| Lorazepam | 13 | $92 | $7 |
| Alprazolam | 16 | $57 | $4 |
Money from drug and device companies
$531 in 2025
| 2025 | 3 | 14 | None | $531 |
| 2024 | 6 | 16 | None | $1,663 |
| 2023 | 3 | 3 | None | $266 |
| 2022 | 5 | 15 | None | $525 |
| 2021 | 6 | 8 | None | $441 |
| 2020 | 1 | 1 | None | $14 |
| 2019 | 6 | 38 | None | $822 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Farxiga | $223 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $190 | 8 payments
|
| Novo Nordisk | Wegovy | $119 | 1 payment
|
See all 14 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-09 | Eliquis | $1 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-09 | Eliquis | $9 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-12 | Farxiga | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-07 | Farxiga | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-06 | Camzyos | $123 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Farxiga | $135 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-03 | Farxiga | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-30 | Farxiga | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-19 | Camzyos | $8 |
| Novo Nordisk | Meals · 2025-04-17 | Wegovy | $119 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-27 | Eliquis | $6 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-27 | Eliquis | $2 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-19 | Camzyos | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-23 | Camzyos | $12 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,663
| Medtronic | Micra | $1,185 | 10 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $153 | 1 payment
|
| Amgen | Repatha | $149 | 1 payment
|
| Novo Nordisk | None | $119 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $40 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
2023: $266
| Janssen Scientific Affairs | Xarelto | $146 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $95 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $26 | 1 payment
|
2022: $525
| E.R. Squibb & Sons L.L.C. | Eliquis | $206 | 10 payments
|
| Merck Sharp & Dohme | Verquvo | $141 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $125 | 1 payment
|
| Abbott Laboratories | Xience Sierra | $28 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $24 | 1 payment
|
2021: $441
| Ablative Solutions | None | $251 | 2 payments
|
| Janssen Scientific Affairs | Xarelto | $94 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $38 | 1 payment
|
| Medtronic | Micra | $29 | 2 payments
|
| Medicomp | Ambulatory Cardiac Monitor | $14 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Verquvo | $14 | 1 payment
|
2020: $14
| Medtronic Vascular | Reveal Linq | $14 | 1 payment
|
2019: $822
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $198 | 28 payments
|
| Pfizer | Eliquis | $148 | 3 payments
|
| Medtronic Vascular | 3f | $123 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $118 | 1 payment
|
| Amarin Pharma | Vascepa | $118 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $116 | 1 payment
|
Checkups this office reported
7 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 1,072 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 91%That's most of the people this applied to. | 136 |
| Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 100% | 107 |
| Coronary Artery Disease (CAD): Antiplatelet TherapyAs Medicare defines this measure | 100% | 363 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 650 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 1,132 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,351 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Implementation of improvements that contribute to more timely communication of test results
- Implementation of medication management practice improvements
- ONC-ACB Surveillance Attestation
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Reports immunizations to the state registry
- Screens for social needs
- Exempt from electronic case reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
- Exempt from support electronic referral loops by receiving and reconciling health information
- Exempt from support electronic referral loops by sending health information
Professional record
- NPI
- 1952305971
- Licence
- CA A45522California A45522: Current · expires 2027-12-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A455220
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 200 Jose Figueres Ave Ste 215, Ste 215, San Jose, CA, 95116
- NPI first listed
- 2005-06-08
- NPI last updated
- 2012-12-09
This is when the NPI record was last certified, not a medical board exam.